Extracorporeal photochemotherapy for the treatment of chronic graft‐versus‐host disease: trend for a possible cell dose‐related effect?
Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …
Extracorporeal photopheresis in the treatment of chronic graft-versus-host disease. The Hellenic experience: a study by the Hellenic association of hematology
P Tsirigotis, P Kaloyannidis, A Papalexandri… - … and Apheresis Science, 2012 - Elsevier
The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …
Role of extracorporeal photochemotherapy in patients with refractory chronic graft‐versus‐host disease
P Rubegni, A Cuccia, P Sbano… - British journal of …, 2005 - Wiley Online Library
Recent studies suggest that extracorporeal photochemotherapy (ECP) may be beneficial in
patients with steroid‐refractory chronic graft‐versus‐host disease (cGvHD). However, it is …
patients with steroid‐refractory chronic graft‐versus‐host disease (cGvHD). However, it is …
Response and survival of patients with chronic graft‐versus‐host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical …
BACKGROUND: Chronic graft‐versus‐host disease (cGVHD) classification has recently
been improved by the National Institutes of Health (NIH); patients' stratification with those …
been improved by the National Institutes of Health (NIH); patients' stratification with those …
A critical appraisal of extracorporeal photopheresis as a treatment modality for acute and chronic graft-versus-host disease
Although significant advances have been made in the biologic understanding of graft-versus-
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …
Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host …
M Nygaard, T Karlsmark, NS Andersen… - Bone Marrow …, 2019 - nature.com
Improvement in chronic graft vs. host disease (cGvHD) following treatment with
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …
extracorporeal photopheresis (ECP) has been shown previously. However, the effect is often …
Update on extracorporeal photochemotherapy for graft-versus-host disease treatment
J Kanold, C Messina, P Halle, F Locatelli… - Bone marrow …, 2005 - nature.com
Pediatric experience with extracorporeal photochemotherapy (ECP) for graft-versus-host
disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 …
disease (GvHD) has mainly been reported by Italian and French groups. Data concerning 41 …
Extracorporeal photochemotherapy for the treatment of graft‐versus‐host disease
R Dall'Amico, C Messina - Therapeutic Apheresis, 2002 - Wiley Online Library
Photopheresis (extracorporeal photochemotherapy, ECP) is a new type of
photochemotherapy used for the treatment of oncological and autoimmune diseases …
photochemotherapy used for the treatment of oncological and autoimmune diseases …
Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy
E Bisaccia, M Palangio, J Gonzalez, KR Adler… - Bone marrow …, 2003 - nature.com
Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory therapy,
has previously demonstrated promising results in treating chronic graft-versus-host disease …
has previously demonstrated promising results in treating chronic graft-versus-host disease …
Extracorporeal photochemotherapy in graft‐versus‐host disease: a longitudinal study on factors influencing the response and survival in pediatric patients
BACKGROUND: Extracorporeal photochemotherapy (ECP) is a valid therapeutic option in
the treatment of acute and chronic graft‐versus‐host disease (aGVHD and cGVHD …
the treatment of acute and chronic graft‐versus‐host disease (aGVHD and cGVHD …
相关搜索
- cell dose extracorporeal photochemotherapy
- host disease extracorporeal photochemotherapy
- immunologic mechanisms extracorporeal photochemotherapy
- response and survival extracorporeal photochemotherapy
- host disease response and survival
- pediatric patients extracorporeal photochemotherapy
- host disease pediatric patients
- treatment cycles dose of cd3
- extracorporeal photopheresis dose of cd3
- treatment cycles extracorporeal photopheresis
- national institutes extracorporeal photochemotherapy
- survival of patients extracorporeal photochemotherapy
- extracorporeal photopheresis treatment modality